Department of Medicine

October 17, 2023

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.

By Jill Clendening

October 16, 2023

ICU antibiotics may be safe for kidneys

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.

By Craig Boerner

October 5, 2023

Study finds no difference in heart transplant outcomes using organs donated after circulatory death and after brain death

A Vanderbilt study found no difference in one-year survival and other outcomes among heart transplant patients who received their new organs from from donation after circulatory death and donation after brain death.

By Matt Batcheldor

October 5, 2023

Stenner and Webber lead collaborative team to win AMA Precision Education Innovation Grant

Shane Stenner, MD, MS, and Chase Webber, DO, and a collaborative team of experts at Vanderbilt University School of Medicine (VUSM) and Vanderbilt University Medical Center were recently named to receive the American Medical Association’s ChangeMedEd Innovation grant.

By Mia Garchitorena-Scancarelli

October 5, 2023

Kidney disease gene also has a protective mutation

African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.